China PharmaHub and Illumibrite Enter Exclusive Distribution Agreement

BOSTON, Feb. 7, 2011 /PRNewswire/ -- China PharmaHub Corp. (OTC Bulletin Board Symbol: CPHB), a biopharmaceutical acquisition and development company, today announced that it has signed an exclusive agreement to be a distributor for Illumibrite LLC, which markets the Illumibrite Professional Teeth Whitening System and Gel Savers Trays in the U.S. China PharmaHub will have the exclusive distribution rights in China, Hong Kong, Taiwan and Macau (the "Greater China Region") for the promotion, sale and delivery of Illumibrite's product line.

"This exclusive distribution agreement between China PharmaHub and Illumibrite is part of our broader strategic effort to bring U.S. healthcare products to the Greater China Region," said Richard Lui, CEO of China PharmaHub. "We look forward to utilizing our network of resources in China to help bring Illumibrite's exciting products to the China markets."

The Illumibrite Professional Teeth Whitening System utilizes either a pen applicator and mini LED accelerator light or tray and gel syringe method, to help whiten the appearance of teeth, using a carbimide peroxide-based gel. The company also distributes Gel Savers Trays, which are custom-molded dental trays for use with a whitening gel.

Illumibrite's CEO Michal Pospieszalski said, "China PharmaHub's resources in China represent a unique opportunity for Illumibrite to significantly expand our global market-base, particularly in this large and fast-growing market. We look forward to working with China PharmaHub to help realize this goal."

About China PharmaHub Corp.

China PharmaHub Corp. is a development stage company engaged in the business of licensing, developing and commercializing innovative products for a wide variety of human diseases from biopharmaceutical companies based in the United States or China. PharmaHub brings a unique blend of relationships and resources to assist scientists and companies to develop, commercialize, market and sell pharmaceutical, biotechnology and healthcare products, as well as offer improved, cost-effective alternatives to current methods of treatment or enable the discovery, research and development of new medicines. PharmaHub's corporate headquarters are located in Los Angeles and Boston. More information on China PharmaHub is available at www.chnpharmahub.com.

Forward-Looking Statements

This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein.

SOURCE China PharmaHub Corp.